Jon Piganelli

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Jon Piganelli and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Jon

Jon Piganelli

Associate Professor

University of Pittsburgh School of Medicine

Dr. Piganelli's group has been involved in studying immunology and autoimmunity; more specifically type 1 diabetes (T1D).

Talks About
#Leader #leadership

Preferred Locations
#NorthAmerica

Speaking Engagements

Lag-3 Targeted Drug Development Summit

Paid

With the recent clinical validation by BMS, LAG-3 combinations are spearheading the next wave of immune checkpoint inhibitors. As such, there has been an explosion of interest and high-scale investment into this exciting space.

25-27 January 2022

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Jon Piganelli

Associate Professor

Speaking Engagements

Lag-3 Targeted Drug Development Summit